Search

Showing "11155" results for ""

Microbicides could increase HIV infections in certain circumstances, models predict

Adherence to ARV prevention methods is challenging, partly because they don’t treat illness

Evidence of effective adherence interventions is still limited

Lost funding means lost lives, says MSF

Eliminate bottlenecks to end mother-to-child HIV transmission

Harm reduction and human rights

Collaborative TB and HIV services for drug users

New WHO treatment criteria could prevent 90% of vertical transmission

Fat loss caused by some anti-HIV drugs persists in the long term

What happens to people who become HIV positive in prevention trials?

Microbicides: the quest for user-friendly formulations

Treatment and PrEP could be on a ‘collision course’, warns resistance expert

START… and why the time is now

Staying free of hepatitis C

To your health!

HIV-positive women in clinical trials: A gap in the facts

Meta-analysis suggests efavirenz does not increase risk of birth abnormalities

Mining industry in Africa is making TB epidemic worse

Receive the latest HIV research and conference news

Showing "11155" results for ""

Microbicides could increase HIV infections in certain circumstances, models predict

Adherence to ARV prevention methods is challenging, partly because they don’t treat illness

Evidence of effective adherence interventions is still limited

Lost funding means lost lives, says MSF

Eliminate bottlenecks to end mother-to-child HIV transmission

Harm reduction and human rights

Collaborative TB and HIV services for drug users

New WHO treatment criteria could prevent 90% of vertical transmission

Fat loss caused by some anti-HIV drugs persists in the long term

What happens to people who become HIV positive in prevention trials?

Microbicides: the quest for user-friendly formulations

Treatment and PrEP could be on a ‘collision course’, warns resistance expert

START… and why the time is now

Staying free of hepatitis C

To your health!

HIV-positive women in clinical trials: A gap in the facts

Meta-analysis suggests efavirenz does not increase risk of birth abnormalities

Mining industry in Africa is making TB epidemic worse

Receive the latest HIV research and conference news